Medtronic Receives FDA Breakthrough Designation for Developing Personalized Closed Loop Insulin Pump System for Diabetes Management
Go back to Medtronic Receives FDA Breakthrough Designation for Developing Personalized Closed Loop Insulin Pump System for Diabetes Management| Medtronic Inc. (NYSE: MDT) | Delayed: 80.63 +1.36 (1.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.27 | 52 Week High | $89.27 | |||
| Open | $79.75 | 52 Week Low | $71.03 | |||
| Day High | $80.75 | P/E | 22.91 | |||
| Day Low | $79.58 | EPS | $3.52 | |||
| Volume | 8,482,506 | |||||
